COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity

Oksana Boyarchuk; Lilya Predyk; Iryna Yuryk

eISSN: 2084-9834
ISSN: 0034-6233

Reumatologia/Rheumatology Supplements

Current supplement Archive Rheumatology

Editorial System

Submit your Manuscript

1/2021

Send email

Copy url:

abstract:

COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity

Oksana Boyarchuk

¹

,

Lilya Predyk

¹

,

Iryna Yuryk

²

Department of Children’s Diseases and Pediatric Surgery, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

Regional Children’s Hospital, Ternopil, Ukraine

Online publish date: 2021/09/08

View full text Get citation

The aim of the study was to determine the frequency and the course of COVID-19 infection in children with juvenile idiopathic arthritis (JIA). The study involved 51 patients with JIA aged 2 to 18 years. Evidence of COVID-19 was found in 10 (19.6%) patients with JIA. COVID-19 infection occurred more often in patients with systemic arthritis (OR = 6.1667, 95% CI: 1.2053–31.5511, p = 0.0289). The course of COVID-19 infection in patients with JIA was generally similar to the course in the pediatric population, despite immunosuppressive therapy. In 3 out of 10 patients the infection caused an exacerbation of JIA, which required therapy escalation.

keywords:

COVID-19 in patients with juvenile idiopathic arthritis: frequency and severity

Oksana Boyarchuk 1 , Lilya Predyk 1 , Iryna Yuryk 2

COVID-19 infection, juvenile idiopathic arthritis, immunosuppressive therapy

Oksana Boyarchuk

¹

,

Lilya Predyk

¹

,

Iryna Yuryk

²